0017 (0017) Fair Value & Analysis

Real Estate · Market cap HK$15.9B

0 0017 0017 · HK

PriceHK$6.33

Fair ValueHK$6.07

Upside-4.1%

Quality42/100

Evidence: Medium Range HK$4.56 – HK$7.61

Fair value as of: Jul 1, 2026

From 8 valuation models · updated today

Share price −23.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$5.10 – HK$11.38 · fair‑value band HK$4.56 – HK$7.61 · the HK$6.33 price screens above the HK$6.07 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0017 (0017) currently trades at HK$6.33, while our model-based Fair Value estimate is HK$6.07 — implying the stock looks roughly 4.1% overvalued today. We read business quality at 42/100 (below-average quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 0017 generated revenue of HK$19.3B at a net margin of -63.8%. Revenue declined 50.0% year over year. It earns a return on equity of -6.5%. Net debt stands at HK$130B. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$19.3B

Revenue growth (YoY) -50.0%

Net margin -63.8%

Return on equity -6.5%

Free cash flow −HK$656M FY2025

Operating margin 9.6%

More key figures

EPS (TTM) HK$-4.19

EPS growth (YoY) -14.3%

Net debt HK$130B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0017 reported revenue of HK$27.7B in FY2025 versus HK$68.5B in FY2021, a compound −20.2%/yr. Reported net income was −HK$15.3B in FY2025.

Revenue −20.2%/yr

FY21 HK$68.5B

FY22 HK$68.2B

FY23 HK$95.6B

FY24 HK$35.8B

FY25 HK$27.7B

Net income

FY21 HK$1.2B

FY22 HK$1.2B

FY23 HK$901M

FY24 −HK$17.5B

FY25 −HK$15.3B

Is 0017 fairly valued? → Check now

Similar stocks

6 more Real Estate - Diversified stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
Mitsubishi Estate Co MITEY	$24.70	$13.49	-45%
Mitsui Fudosan Co MTSFF	$9.40	$10.25	+9%
Henderson Land Development Company HLDVF	$3.70	$2.19	-41%
Swiss Prime Site AG SPSN	CHF 129.50	CHF 40.79	-69%
Central Pattana Public Company CPNR	64.00 THB	84.32 THB	+32%
SM Prime Holdings SPHXF	$0.2801	$0.6700	+139%

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0017 (0017) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$6.07 versus a price of HK$6.33 — about −4% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0017?

Our model-based fair value for 0017 is HK$6.07 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$6.33.

What is the quality score of 0017?

0017 has a Quality Score of 42/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0017 (0017)?

0017 reported trailing-twelve-month revenue of about HK$19.3B (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0017?

The net profit margin of 0017 is about -63.8%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.